Source: Annual Congress 2001 - COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Stolk (Leiden, The Netherlands). Mortality of patients with emphysema and alpha-1-antitrypsin deficiency of Pi Z phenotype. Eur Respir J 2001; 16: Suppl. 31, 282

Member's Comments

No comment yet.

Related content which might interest you: Mortality in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006 Short-term variability of biomakers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency Source: Eur Respir J 2004; 24: Suppl. 48, 459s Year: 2004 Prevalence of alpha-1-antitrypsin deficiency (A1AD) in patients with COPD. Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Young adult with inherited PiMZ alpha-1-antitrypsin deficiency (A1ATD)-related bronchiectasis: characteristic of blood neutrophils and A1AT protein Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Alpha-1-antitrypsin deficiency Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=139 Year: 2005 Risk of cancer in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) compared with the Swedish general population Source: Virtual Congress 2020 – Asthma and COPD: How genetic and environment influences its developement? Year: 2020 Severity of lung disease in siblings with α-1-antitrypsin deficiency (AATD) Source: Annual Congress 2008 - COPD Year: 2008 Prevalence of alpha1-antitrypsin deficiency and its influence on lung function decline in patients with severe asthma Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Severe alpha-1-antitrypsin deficiency (A1ATD) caused by Q0Ourém mutation: A clinical characterization Source: Annual Congress 2010 - Genetics of obstruction Year: 2010 Does urinary peptide content differ between COPD patients with and without inherited alpha1-antitrypsin deficiency? Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Effect of danazol on acute phase reactants in patients with PiM, PiMZ and PiZ phenotypes for alpha-1-antitrypsin deficiency Source: Eur Respir J 2001; 18: Suppl. 33, 249s Year: 2001 Use of measurements of airway resistance in the determination of reversibility in patients with emphysema associated with alpha-1-antitrypsin (A1ATD) deficiency Source: Eur Respir J 2001; 18: Suppl. 33, 205s Year: 2001 Erythrocyte abnormalities in alpha-1-antitrypsin deficiency (AATD) patients Source: Annual Congress 2009 - COPD: exacerbation and clinical problems Year: 2009 Proteinase 3 activity is present in sputum from subjects with alpha-1-antitrypsin deficiency (AATD) and COPD Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012 Health status changes in alpha-1-antitrypsin deficiency (PiZ phenotype) over 3 years Source: Annual Congress 2003 - Alpha-1 antitrypsin deficiency and COPD Year: 2003 Pulmonary disease in intermediate alpha1-antitrypsin deficient patients Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 Screening for α1-Pi deficiency in patients with lung diseases Source: Eur Respir J 2002; 20: 319-324 Year: 2002 Lung function decline in relation to alpha-1-antitrypsin phenotypes in severe asthma Source: Eur Respir J 2003; 22: Suppl. 45, 479s Year: 2003 Krüppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency Source: Annual Congress 2012 - New mechanisms in non-neoplastic and neoplastic lung diseases Year: 2012 Serum vitamin D level is associated with emphysema progression in male patients with COPD Source: International Congress 2017 – Markers of COPD progression Year: 2017